SSY Group Limited (HKG: 2005)

Market Cap	11.45B
Revenue (ttm)	6.47B
Net Income (ttm)	1.37B
Shares Out	2.97B
EPS (ttm)	0.46
PE Ratio	8.41
Forward PE	8.15
Dividend	0.18 (4.66%)
Ex-Dividend Date	Sep 12, 2024

Volume	1,256,000
Open	3.840
Previous Close	3.860
Day's Range	3.780 - 3.880
52-Week Range	3.310 - 5.200
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 10, 2024

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk ph...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,640
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2023, SSY Group's revenue was 6.46 billion, an increase of 0.45% compared to the previous year's 6.43 billion. Earnings were 1.32 billion, an increase of 17.44%.